HIND - ReShape Lifesciences Inc.

2.26
-0.090   -3.982%

Share volume: 24,962
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$2.35
-0.09
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 35%
Dept financing 42%
Liquidity 37%
Performance 37%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.26%
1 Month
-2.59%
3 Months
-22.47%
6 Months
-58.53%
1 Year
472.73%
2 Year
1,254.10%
Key data
Stock price
$2.26
P/E Ratio 
N/A
DAY RANGE
$2.25 - $2.36
EPS 
$13.30
52 WEEK RANGE
$0.32 - $16.00
52 WEEK CHANGE
$479.49
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
1.69
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$24,673
AVERAGE 30 VOLUME 
$19,844
Company detail
CEO: Paul F. Hickey
Region: US
Website: reshapelifesciences.com
Employees: 50
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. Its product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes.

Recent news